Results 31 to 40 of about 760,866 (212)

Landscape of pathogenic mutations in premature ovarian insufficiency

Nature Medicine, 2023
Premature ovarian insufficiency (POI) is a major cause of female infertility due to early loss of ovarian function. POI is a heterogeneous condition, and its molecular etiology is unclear.
Hanni Ke, Shuyan Tang, T. Guo, Dong Hou, X. Jiao, Shan Li, Wei Luo, Bing-Ying Xu, Shi-Dou Zhao, Guangyu Li, Xiaoxi Zhang, Shu-Hua Xu, Ling-Bo Wang, Yan-Hua Wu, Jiu-Cun Wang, Feng Zhang, Ying-Ying Qin, Li Jin, Zi-Jiang Chen   +18 more
semanticscholar   +1 more source

Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation

Reproductive Biology and Endocrinology, 2020
Premature Ovarian Insufficiency (POI) is viewed as a type of infertility in which the menopausal status occurs before the physiological age. Several therapeutic strategies have been introduced in clinic for POI treatment, although the outputs are not ...
S. Ahmadian, Sepideh Sheshpari, M. Pazhang, A. M. Bedate, R. Beheshti, M. Abbasi, M. Nouri, R. Rahbarghazi, Mahdi Mahdipour   +8 more
semanticscholar   +1 more source

How to Prevent Early Ovulation/Luteinization During an IVF Cycle

Fertility & Reproduction, 2023
In ovarian stimulation for artificial reproductive medicine, we sometimes encounter progesterone elevation (PL; Premature luteinization) on the day of ovulation trigger.
Yoshiharu Morimoto
doaj   +1 more source

A flexible short protocol in women with poor ovarian response over 40 years old

Journal of Ovarian Research, 2021
Background Ovarian responsiveness to controlled ovarian stimulation is essential for a successful clinical outcome in assisted reproductive technology (ART) cycles. We aimed to find a suitable new ovulation stimulation protocol for poor ovarian response (
Xinyue Zhang, Ting Feng, Jihong Yang, Yingying Hao, Suying Li, Yan Zhang, Yun Qian   +6 more
doaj   +1 more source

Multilevel model to assess sources of variation in follicular growth close to the time of ovulation in women with normal fertility: a multicenter observational study [PDF]

, 2008
Mikolajczyk RT, Stanford JB, Ecochard R. Multilevel model to assess sources of variation in follicular growth close to the time of ovulation in women with normal fertility: a multicenter observational study. Reproductive Biology and Endocrinology. 2008;6(
Stanford Joseph B, Mikolajczyk Rafael T, Ecochard René, Mikolajczyk, Rafael T., Ecochard, Rene, Joseph B Stanford, Stanford, Joseph B., Rafael T Mikolajczyk, René Ecochard   +8 more
core   +1 more source

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation

F&S Reports, 2023
I describe how we identified the need to block the luteinizing hormone (LH) surge when trying to control the processes of luteinization and ovulation within the clinic.
Richard Fleming, Ph.D.
doaj   +1 more source

The new WHO infertility guideline: A universal right to equitable, evidence-based fertility care. [PDF]

Int J Gynaecol Obstet
Abstract The WHO ‘Guideline for the prevention, diagnosis and treatment of infertility’ heralds a significant global shift towards recognizing infertility as a medical condition requiring prevention, diagnosis, treatment and policy support. This recognition is vital for the one in six people with infertility worldwide and for policymakers trying to ...
Hull ML, Barnhart KT, Purandare NC, Sridhar A, Topçu EG, Nelson SM, FIGO REI committee.   +6 more
europepmc   +2 more sources

Correlation between serum progesterone level on the day of ovulation trigger during In vitro fertilization and its effect on treatment outcome

Journal of Human Reproductive Sciences, 2019
Background: Premature luteinization (PL) is defined as a premature rise in serum progesterone concentration on or before the day of ovulation trigger with human chorionic gonadotropin.
N Nagaraja, Pankaj Talwar, Bhaskar Mukherjee, Barun Kumar Chakrabarty   +3 more
doaj   +1 more source

A patient and physician friendly stimulation protocol using long acting FSH and progestin priming should be the future of IVF

Clinical and Experimental Obstetrics & Gynecology, 2022
Objective: Needle phobias and concern about the discomfort remain significant disincentives for many women contemplating in vitro fertilization (IVF).
Einav Kadour-Peero, Michael H. Dahan
doaj   +1 more source

Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. [PDF]

, 2009
To assess long-term health effects of ovarian-stimulation drugs we followed-up for over 20 years a British cohort of 7355 women with ovulatory disorders, 43% of whom were prescribed ovarian-stimulation drugs, and identified a total of 274 deaths and 367 ...
Overton, C, V A McCormack, Dos Santos Silva, I, McCormack, VA, Wark, PA, Little, V., Overton, C., Hardiman, P, McCormack, V. A., P A Wark, Nieto, J., Davies, M, Davies, M., I dos Santos Silva, Little, V, A B MacLean, P Hardiman, MacLean, A. B., Nieto, J, M Davies, Dos Santos Silva, I., Mayer, D, J Nieto, Silva, I dos Santos, Wark, P. A.; id_orcid, Hardiman, P., C Overton, V Little, Maclean, AB, D Mayer, Mayer, D.   +30 more
core   +1 more source